Comprehensive metabolic profiling of Parkinson’s disease by liquid chromatography-mass spectrometry

This study may help improve our understanding of PD etiopathogenesis and facilitate target screening for therapeutic intervention. The metabolite panel identified in this study may provide novel approach for the clinical diagnosis of PD in the future.